Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
Condition(s):OsteosarcomaLast Updated:November 2, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):OsteosarcomaLast Updated:November 2, 2023Recruiting
Condition(s):Vertebral MetastasisLast Updated:April 28, 2022Recruiting
Condition(s):Sarcoma; Sarcoma,Soft Tissue; Sarcoma of BoneLast Updated:October 31, 2023Recruiting
Condition(s):Head and Neck CancerLast Updated:May 23, 2023Not yet recruiting
Condition(s):Prostate Cancer; Radiotherapy; SBRTLast Updated:December 7, 2023Recruiting
Condition(s):Spine MetastasesLast Updated:December 27, 2023Recruiting
Condition(s):Pancreatic Adenocarcinoma; Pancreatic Cancer Non-resectableLast Updated:July 19, 2023Recruiting
Condition(s):Breast Cancer; Oligometastasis; Metastatic Breast CancerLast Updated:December 19, 2023Recruiting
Condition(s):Pancreatic CancerLast Updated:April 14, 2022Recruiting
Condition(s):Colorectal CancerLast Updated:March 19, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.